 | • レポートコード：C-GIR20G2124 • 出版社/出版日：GlobalInfoResearch / 2019年12月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「合成ポリペプチド薬の世界市場2019年」は、グローバルにおける合成ポリペプチド薬市場を展望するレポートです。合成ポリペプチド薬のグローバル市場概観、メーカー動向、メーカー別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載しています。 ・合成ポリペプチド薬の市場概観 ・合成ポリペプチド薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・合成ポリペプチド薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・合成ポリペプチド薬の世界市場規模 ・合成ポリペプチド薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・合成ポリペプチド薬のアメリカ市場規模推移 ・合成ポリペプチド薬のカナダ市場規模推移 ・合成ポリペプチド薬のメキシコ市場規模推移 ・合成ポリペプチド薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・合成ポリペプチド薬のドイツ市場規模推移 ・合成ポリペプチド薬のイギリス市場規模推移 ・合成ポリペプチド薬のロシア市場規模推移 ・合成ポリペプチド薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・合成ポリペプチド薬の日本市場規模推移 ・合成ポリペプチド薬の中国市場規模推移 ・合成ポリペプチド薬の韓国市場規模推移 ・合成ポリペプチド薬のインド市場規模推移 ・合成ポリペプチド薬の東南アジア市場規模推移 ・合成ポリペプチド薬の南米市場分析（ブラジル、アルゼンチン等） ・合成ポリペプチド薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・合成ポリペプチド薬の種類別分析/販売量、売上、市場シェア（免疫調節薬（アレルギー感染＆免疫）、消化器系薬（胃腸型）、骨および結合組織型（甲状腺ホルモン薬）、婦人科または産科薬、腫瘍薬（hCG）、尿系薬（尿崩症）、その他） ・合成ポリペプチド薬の用途別分析/市場規模（遺伝子送達、薬物送達、バイオイメージング、組織工学、抗菌薬、その他） ・合成ポリペプチド薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・合成ポリペプチド薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Synthesis Polypeptide Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Synthesis Polypeptide Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Hainan Zhonghe Pharmaceutical
PolyPeptide
Ferring Pharmaceuticals
Thermo Fisher Scientific
Novartis
Merck Millipore
CPC Scientific
HYBIO Pharmaceutical
AstraZeneca
Abzena
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Immunity Regulating Medicine (Allergy Infection and Immune)
Digestive System Drugs (Gastrointestinal Type)
Bone and Connective Tissue Types (Thyroid hormones Drug)
Gynecologic or Obstetric Drug
Tumor Drug (hCG)
Urinary System Drug (Diabetes Insipidus)
Other
Market Segment by Applications, can be divided into
Gene Delivery
Drug Delivery
Bio-Imaging
Tissue Engineering
Antimicrobials
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Synthesis Polypeptide Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Synthesis Polypeptide Drugs, with price, sales, revenue and global market share of Synthesis Polypeptide Drugs in 2017 and 2018.
Chapter 3, the Synthesis Polypeptide Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Synthesis Polypeptide Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Synthesis Polypeptide Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Synthesis Polypeptide Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Synthesis Polypeptide Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Immunity Regulating Medicine (Allergy Infection and Immune)
1.2.2 Digestive System Drugs (Gastrointestinal Type)
1.2.3 Bone and Connective Tissue Types (Thyroid hormones Drug)
1.2.4 Gynecologic or Obstetric Drug
1.2.5 Tumor Drug (hCG)
1.2.6 Urinary System Drug (Diabetes Insipidus)
1.2.7 Other
1.3 Market Analysis by Applications
1.3.1 Gene Delivery
1.3.2 Drug Delivery
1.3.3 Bio-Imaging
1.3.4 Tissue Engineering
1.3.5 Antimicrobials
1.3.6 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Hainan Zhonghe Pharmaceutical
2.1.1 Business Overview
2.1.2 Synthesis Polypeptide Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Hainan Zhonghe Pharmaceutical Synthesis Polypeptide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 PolyPeptide
2.2.1 Business Overview
2.2.2 Synthesis Polypeptide Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 PolyPeptide Synthesis Polypeptide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Ferring Pharmaceuticals
2.3.1 Business Overview
2.3.2 Synthesis Polypeptide Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Ferring Pharmaceuticals Synthesis Polypeptide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Thermo Fisher Scientific
2.4.1 Business Overview
2.4.2 Synthesis Polypeptide Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Thermo Fisher Scientific Synthesis Polypeptide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Novartis
2.5.1 Business Overview
2.5.2 Synthesis Polypeptide Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novartis Synthesis Polypeptide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Merck Millipore
2.6.1 Business Overview
2.6.2 Synthesis Polypeptide Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Merck Millipore Synthesis Polypeptide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 CPC Scientific
2.7.1 Business Overview
2.7.2 Synthesis Polypeptide Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 CPC Scientific Synthesis Polypeptide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 HYBIO Pharmaceutical
2.8.1 Business Overview
2.8.2 Synthesis Polypeptide Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 HYBIO Pharmaceutical Synthesis Polypeptide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 AstraZeneca
2.9.1 Business Overview
2.9.2 Synthesis Polypeptide Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 AstraZeneca Synthesis Polypeptide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Abzena
2.10.1 Business Overview
2.10.2 Synthesis Polypeptide Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Abzena Synthesis Polypeptide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Synthesis Polypeptide Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Synthesis Polypeptide Drugs Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Synthesis Polypeptide Drugs Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Synthesis Polypeptide Drugs Manufacturer Market Share in 2018
3.3.2 Top 6 Synthesis Polypeptide Drugs Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Synthesis Polypeptide Drugs Market Analysis by Regions
4.1 Global Synthesis Polypeptide Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Synthesis Polypeptide Drugs Sales and Market Share by Regions (2014-2019)
4.1.2 Global Synthesis Polypeptide Drugs Revenue and Market Share by Regions (2014-2019)
4.2 North America Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
4.3 Europe Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
4.5 South America Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
5 North America Synthesis Polypeptide Drugs by Country
5.1 North America Synthesis Polypeptide Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Synthesis Polypeptide Drugs Sales and Market Share by Country (2014-2019)
5.1.2 North America Synthesis Polypeptide Drugs Revenue and Market Share by Country (2014-2019)
5.2 United States Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
5.3 Canada Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
5.4 Mexico Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
6 Europe Synthesis Polypeptide Drugs by Country
6.1 Europe Synthesis Polypeptide Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Synthesis Polypeptide Drugs Sales and Market Share by Country (2014-2019)
6.1.2 Europe Synthesis Polypeptide Drugs Revenue and Market Share by Country (2014-2019)
6.2 Germany Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
6.3 UK Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
6.4 France Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
6.5 Russia Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
6.6 Italy Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
7 Asia-Pacific Synthesis Polypeptide Drugs by Country
7.1 Asia-Pacific Synthesis Polypeptide Drugs Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Synthesis Polypeptide Drugs Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Synthesis Polypeptide Drugs Revenue and Market Share by Country (2014-2019)
7.2 China Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
7.3 Japan Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
7.4 Korea Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
7.5 India Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
8 South America Synthesis Polypeptide Drugs by Country
8.1 South America Synthesis Polypeptide Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Synthesis Polypeptide Drugs Sales and Market Share by Country (2014-2019)
8.1.2 South America Synthesis Polypeptide Drugs Revenue and Market Share by Country (2014-2019)
8.2 Brazil Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
8.3 Argentina Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
8.4 Colombia Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
9 Middle East and Africa Synthesis Polypeptide Drugs by Countries
9.1 Middle East and Africa Synthesis Polypeptide Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Synthesis Polypeptide Drugs Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Synthesis Polypeptide Drugs Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
9.3 Turkey Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
9.4 Egypt Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
9.5 Nigeria Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
9.6 South Africa Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
10 Global Synthesis Polypeptide Drugs Market Segment by Type
10.1 Global Synthesis Polypeptide Drugs Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Synthesis Polypeptide Drugs Sales and Market Share by Type (2014-2019)
10.1.2 Global Synthesis Polypeptide Drugs Revenue and Market Share by Type (2014-2019)
10.2 Immunity Regulating Medicine (Allergy Infection and Immune) Sales Growth and Price
10.2.1 Global Immunity Regulating Medicine (Allergy Infection and Immune) Sales Growth (2014-2019)
10.2.2 Global Immunity Regulating Medicine (Allergy Infection and Immune) Price (2014-2019)
10.3 Digestive System Drugs (Gastrointestinal Type) Sales Growth and Price
10.3.1 Global Digestive System Drugs (Gastrointestinal Type) Sales Growth (2014-2019)
10.3.2 Global Digestive System Drugs (Gastrointestinal Type) Price (2014-2019)
10.4 Bone and Connective Tissue Types (Thyroid hormones Drug) Sales Growth and Price
10.4.1 Global Bone and Connective Tissue Types (Thyroid hormones Drug) Sales Growth (2014-2019)
10.4.2 Global Bone and Connective Tissue Types (Thyroid hormones Drug) Price (2014-2019)
10.5 Gynecologic or Obstetric Drug Sales Growth and Price
10.5.1 Global Gynecologic or Obstetric Drug Sales Growth (2014-2019)
10.5.2 Global Gynecologic or Obstetric Drug Price (2014-2019)
10.6 Tumor Drug (hCG) Sales Growth and Price
10.6.1 Global Tumor Drug (hCG) Sales Growth (2014-2019)
10.6.2 Global Tumor Drug (hCG) Price (2014-2019)
10.7 Urinary System Drug (Diabetes Insipidus) Sales Growth and Price
10.7.1 Global Urinary System Drug (Diabetes Insipidus) Sales Growth (2014-2019)
10.7.2 Global Urinary System Drug (Diabetes Insipidus) Price (2014-2019)
10.8 Other Sales Growth and Price
10.8.1 Global Other Sales Growth (2014-2019)
10.8.2 Global Other Price (2014-2019)
11 Global Synthesis Polypeptide Drugs Market Segment by Application
11.1 Global Synthesis Polypeptide Drugs Sales Market Share by Application (2014-2019)
11.2 Gene Delivery Sales Growth (2014-2019)
11.3 Drug Delivery Sales Growth (2014-2019)
11.4 Bio-Imaging Sales Growth (2014-2019)
11.5 Tissue Engineering Sales Growth (2014-2019)
11.6 Antimicrobials Sales Growth (2014-2019)
11.7 Other Sales Growth (2014-2019)
12 Synthesis Polypeptide Drugs Market Forecast (2019-2024)
12.1 Global Synthesis Polypeptide Drugs Sales, Revenue and Growth Rate (2019-2024)
12.2 Synthesis Polypeptide Drugs Market Forecast by Regions (2019-2024)
12.2.1 North America Synthesis Polypeptide Drugs Market Forecast (2019-2024)
12.2.2 Europe Synthesis Polypeptide Drugs Market Forecast (2019-2024)
12.2.3 Asia-Pacific Synthesis Polypeptide Drugs Market Forecast (2019-2024)
12.2.4 South America Synthesis Polypeptide Drugs Market Forecast (2019-2024)
12.2.5 Middle East and Africa Synthesis Polypeptide Drugs Market Forecast (2019-2024)
12.3 Synthesis Polypeptide Drugs Market Forecast by Type (2019-2024)
12.3.1 Global Synthesis Polypeptide Drugs Sales Forecast by Type (2019-2024)
12.3.2 Global Synthesis Polypeptide Drugs Market Share Forecast by Type (2019-2024)
12.4 Synthesis Polypeptide Drugs Market Forecast by Application (2019-2024)
12.4.1 Global Synthesis Polypeptide Drugs Sales Forecast by Application (2019-2024)
12.4.2 Global Synthesis Polypeptide Drugs Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Synthesis Polypeptide Drugs Picture
Table Product Specifications of Synthesis Polypeptide Drugs
Figure Global Sales Market Share of Synthesis Polypeptide Drugs by Types in 2018
Table Synthesis Polypeptide Drugs Types for Major Manufacturers
Figure Immunity Regulating Medicine (Allergy Infection and Immune) Picture
Figure Digestive System Drugs (Gastrointestinal Type) Picture
Figure Bone and Connective Tissue Types (Thyroid hormones Drug) Picture
Figure Gynecologic or Obstetric Drug Picture
Figure Tumor Drug (hCG) Picture
Figure Urinary System Drug (Diabetes Insipidus) Picture
Figure Other Picture
Figure Synthesis Polypeptide Drugs Sales Market Share by Applications in 2018
Figure Gene Delivery Picture
Figure Drug Delivery Picture
Figure Bio-Imaging Picture
Figure Tissue Engineering Picture
Figure Antimicrobials Picture
Figure Other Picture
Figure United States Synthesis Polypeptide Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Synthesis Polypeptide Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Synthesis Polypeptide Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Synthesis Polypeptide Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure France Synthesis Polypeptide Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure UK Synthesis Polypeptide Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Synthesis Polypeptide Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Synthesis Polypeptide Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure China Synthesis Polypeptide Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Synthesis Polypeptide Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Synthesis Polypeptide Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure India Synthesis Polypeptide Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Synthesis Polypeptide Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Synthesis Polypeptide Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Synthesis Polypeptide Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Synthesis Polypeptide Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Synthesis Polypeptide Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Synthesis Polypeptide Drugs Revenue (Value) and Growth Rate (2014-2024)
Table Hainan Zhonghe Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Hainan Zhonghe Pharmaceutical Synthesis Polypeptide Drugs Type and Applications
Table Hainan Zhonghe Pharmaceutical Synthesis Polypeptide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table PolyPeptide Basic Information, Manufacturing Base and Competitors
Table PolyPeptide Synthesis Polypeptide Drugs Type and Applications
Table PolyPeptide Synthesis Polypeptide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Ferring Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Ferring Pharmaceuticals Synthesis Polypeptide Drugs Type and Applications
Table Ferring Pharmaceuticals Synthesis Polypeptide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table Thermo Fisher Scientific Synthesis Polypeptide Drugs Type and Applications
Table Thermo Fisher Scientific Synthesis Polypeptide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Synthesis Polypeptide Drugs Type and Applications
Table Novartis Synthesis Polypeptide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Millipore Basic Information, Manufacturing Base and Competitors
Table Merck Millipore Synthesis Polypeptide Drugs Type and Applications
Table Merck Millipore Synthesis Polypeptide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table CPC Scientific Basic Information, Manufacturing Base and Competitors
Table CPC Scientific Synthesis Polypeptide Drugs Type and Applications
Table CPC Scientific Synthesis Polypeptide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table HYBIO Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table HYBIO Pharmaceutical Synthesis Polypeptide Drugs Type and Applications
Table HYBIO Pharmaceutical Synthesis Polypeptide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Synthesis Polypeptide Drugs Type and Applications
Table AstraZeneca Synthesis Polypeptide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Abzena Basic Information, Manufacturing Base and Competitors
Table Abzena Synthesis Polypeptide Drugs Type and Applications
Table Abzena Synthesis Polypeptide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Synthesis Polypeptide Drugs Sales by Manufacturer (2017-2018)
Figure Global Synthesis Polypeptide Drugs Sales Market Share by Manufacturer in 2017
Figure Global Synthesis Polypeptide Drugs Sales Market Share by Manufacturer in 2018
Table Global Synthesis Polypeptide Drugs Revenue by Manufacturer (2017-2018)
Figure Global Synthesis Polypeptide Drugs Revenue Market Share by Manufacturer in 2017
Figure Global Synthesis Polypeptide Drugs Revenue Market Share by Manufacturer in 2018
Figure Top 3 Synthesis Polypeptide Drugs Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Synthesis Polypeptide Drugs Manufacturer (Revenue) Market Share in 2018
Figure Global Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
Figure Global Synthesis Polypeptide Drugs Revenue and Growth Rate (2014-2019)
Table Global Synthesis Polypeptide Drugs Sales by Regions (2014-2019)
Table Global Synthesis Polypeptide Drugs Sales Market Share by Regions (2014-2019)
Table Global Synthesis Polypeptide Drugs Revenue by Regions (2014-2019)
Figure Global Synthesis Polypeptide Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Synthesis Polypeptide Drugs Revenue Market Share by Regions in 2018
Figure North America Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
Figure Europe Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
Figure South America Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
Figure North America Synthesis Polypeptide Drugs Revenue and Growth Rate (2014-2019)
Table North America Synthesis Polypeptide Drugs Sales by Countries (2014-2019)
Table North America Synthesis Polypeptide Drugs Sales Market Share by Countries (2014-2019)
Figure North America Synthesis Polypeptide Drugs Sales Market Share by Countries (2014-2019)
Figure North America Synthesis Polypeptide Drugs Sales Market Share by Countries in 2018
Table North America Synthesis Polypeptide Drugs Revenue by Countries (2014-2019)
Table North America Synthesis Polypeptide Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Synthesis Polypeptide Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Synthesis Polypeptide Drugs Revenue Market Share by Countries in 2018
Figure United States Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
Figure Canada Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
Figure Mexico Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
Figure Europe Synthesis Polypeptide Drugs Revenue and Growth Rate (2014-2019)
Table Europe Synthesis Polypeptide Drugs Sales by Countries (2014-2019)
Table Europe Synthesis Polypeptide Drugs Sales Market Share by Countries (2014-2019)
Table Europe Synthesis Polypeptide Drugs Revenue by Countries (2014-2019)
Figure Europe Synthesis Polypeptide Drugs Revenue Market Share by Countries (2014-2019)
Figure Europe Synthesis Polypeptide Drugs Revenue Market Share by Countries in 2018
Figure Germany Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
Figure UK Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
Figure France Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
Figure Russia Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
Figure Italy Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Synthesis Polypeptide Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Synthesis Polypeptide Drugs Sales by Countries (2014-2019)
Table Asia-Pacific Synthesis Polypeptide Drugs Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Synthesis Polypeptide Drugs Sales Market Share by Countries 2018
Table Asia-Pacific Synthesis Polypeptide Drugs Revenue by Countries (2014-2019)
Figure Asia-Pacific Synthesis Polypeptide Drugs Revenue Market Share by Countries 2018
Figure China Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
Figure Japan Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
Figure Korea Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
Figure India Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
Figure Southeast Asia Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
Figure South America Synthesis Polypeptide Drugs Revenue and Growth Rate (2014-2019)
Table South America Synthesis Polypeptide Drugs Sales by Countries (2014-2019)
Table South America Synthesis Polypeptide Drugs Sales Market Share by Countries (2014-2019)
Figure South America Synthesis Polypeptide Drugs Sales Market Share by Countries in 2018
Table South America Synthesis Polypeptide Drugs Revenue by Countries (2014-2019)
Table South America Synthesis Polypeptide Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Synthesis Polypeptide Drugs Revenue Market Share by Countries in 2018
Figure Brazil Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
Figure Argentina Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
Figure Colombia Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Synthesis Polypeptide Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Synthesis Polypeptide Drugs Sales by Countries (2014-2019)
Table Middle East and Africa Synthesis Polypeptide Drugs Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Synthesis Polypeptide Drugs Sales Market Share by Countries in 2018
Table Middle East and Africa Synthesis Polypeptide Drugs Revenue by Countries (2014-2019)
Table Middle East and Africa Synthesis Polypeptide Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Synthesis Polypeptide Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Synthesis Polypeptide Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
Figure UAE Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
Figure Egypt Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
Figure Nigeria Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
Figure South Africa Synthesis Polypeptide Drugs Sales and Growth Rate (2014-2019)
Table Global Synthesis Polypeptide Drugs Sales by Type (2014-2019)
Table Global Synthesis Polypeptide Drugs Sales Share by Type (2014-2019)
Table Global Synthesis Polypeptide Drugs Revenue by Type (2014-2019)
Table Global Synthesis Polypeptide Drugs Revenue Share by Type (2014-2019)
Figure Global Immunity Regulating Medicine (Allergy Infection and Immune) Sales Growth (2014-2019)
Figure Global Immunity Regulating Medicine (Allergy Infection and Immune) Price (2014-2019)
Figure Global Digestive System Drugs (Gastrointestinal Type) Sales Growth (2014-2019)
Figure Global Digestive System Drugs (Gastrointestinal Type) Price (2014-2019)
Figure Global Bone and Connective Tissue Types (Thyroid hormones Drug) Sales Growth (2014-2019)
Figure Global Bone and Connective Tissue Types (Thyroid hormones Drug) Price (2014-2019)
Figure Global Gynecologic or Obstetric Drug Sales Growth (2014-2019)
Figure Global Gynecologic or Obstetric Drug Price (2014-2019)
Figure Global Tumor Drug (hCG) Sales Growth (2014-2019)
Figure Global Tumor Drug (hCG) Price (2014-2019)
Figure Global Urinary System Drug (Diabetes Insipidus) Sales Growth (2014-2019)
Figure Global Urinary System Drug (Diabetes Insipidus) Price (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Other Price (2014-2019)
Table Global Synthesis Polypeptide Drugs Sales by Application (2014-2019)
Table Global Synthesis Polypeptide Drugs Sales Share by Application (2014-2019)
Figure Global Gene Delivery Sales Growth (2014-2019)
Figure Global Drug Delivery Sales Growth (2014-2019)
Figure Global Bio-Imaging Sales Growth (2014-2019)
Figure Global Tissue Engineering Sales Growth (2014-2019)
Figure Global Antimicrobials Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Synthesis Polypeptide Drugs Sales, Revenue and Growth Rate (2019-2024)
Table Global Synthesis Polypeptide Drugs Sales Forecast by Regions (2019-2024)
Table Global Synthesis Polypeptide Drugs Market Share Forecast by Regions (2019-2024)
Figure North America Sales Synthesis Polypeptide Drugs Market Forecast (2019-2024)
Figure Europe Sales Synthesis Polypeptide Drugs Market Forecast (2019-2024)
Figure Asia-Pacific Sales Synthesis Polypeptide Drugs Market Forecast (2019-2024)
Figure South America Sales Synthesis Polypeptide Drugs Market Forecast (2019-2024)
Figure Middle East and Africa Sales Synthesis Polypeptide Drugs Market Forecast (2019-2024)
Table Global Synthesis Polypeptide Drugs Sales Forecast by Type (2019-2024)
Table Global Synthesis Polypeptide Drugs Market Share Forecast by Type (2019-2024)
Table Global Synthesis Polypeptide Drugs Sales Forecast by Application (2019-2024)
Table Global Synthesis Polypeptide Drugs Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
肺薬物デリバリーシステム（PDDS）市場：世界及び中国市場分析・予測（～2024年） Pulmonary Drug Delivery System (PDDS) Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Pulmonary Drug Delivery System (PDDS) industry with a focus on the Chinese market. The report provides key statistics on the market status o…- 世界の経皮/経粘膜ドラッグデリバリーシステム市場予測（～2024年） Transdermal/transmucosal drug delivery is a well-established accepted route of administration for therapeutically beneficial medicines. Transdermal/transmucosal drug delivery continues to play an important role in the development of a variety of therapeutic areas in both brand and generic products. …
- 世界の経皮および経粘膜薬物送達市場予測（～2024年）：企業別、地域別、種類・用途別 When injections and pills are counter-indicated, transdermal and transmucosal delivery systems may get drugs into the body with great efficacy and beneficial results. Scope of the Report: The global Transdermal and Transmucosal Drug Delivery market is valued at xx million USD in 2018 and is expected…
- 世界の埋め込み型および無針ドラッグデリバリー市場予測（～2024年）：企業別、地域別、種類・用途別 Implantable drug delivery system becomes new kind of drug delivery system which can directly implant in the human body to optimize therapeutic properties. The needle-free drug delivery platform technology to transform the administration of medicines and improve the patient experience for chronic dis…
- ドラッグデリバリーシステム市場：世界及び中国市場分析・予測（～2024年） Drug Delivery Systems Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Drug Delivery Systems industry with a focus on the Chinese market. The report provides key statistics on the market status of the Drug Delivery Systems manu…